Drug-induced vasculitides
References (127)
Classification of the necrotizing vasculitides in man
Clinics in Rheumatic Diseases
(1980)- et al.
Allergic cutaneous reactions to drugs
Primary Care; Clinics in Office Practice
(1989) - et al.
Thiazides: a cause of necrotising vasculitis?
Lancet
(1965) - et al.
Cutaneous clinicopathologic correlation of allergic granulomatosis
Journal of the American Academy of Dermatology
(1981) Polyarteritis nodosa after thiouracil
Lancet
(1952)- et al.
Fenoprofen nephropathy: lipoid nephrosis and interstitial nephritis. A possible T-lymphocyte disorder
American Journal of Medicine
(1982) - et al.
Cocaine-induced acute aortic dissection
Chest
(1989) - et al.
Hypersensitivity to procarbazine associated with angioedema, urticaria and low serum complement activity
Journal of Allergy and Clinical Immunology
(1976) - et al.
Leukocytoclastic vasculitis: sequential appearance of immunoreactants and cellular changes in serial biopsies
Journal of Investigative Dermatology
(1977) - et al.
Management of drug allergy in patients with acquired immunodeficiency syndrome
Journal of Allergy and Clinical Immunology
(1987)
Severe allopurinol toxicity. Description and guidelines for prevention in patients with renal insufficiency
American Journal of Medicine
Drug induced and toxic granulomatous hepatitis
Baillière's Clinical Gastroenterology
Possibly thiazide induced renal necrotising vasculitis
Lancet
Cimetidine induced cutaneous vasculitis
American Journal of Medicine
Leukocytoclastic vasculitis after high-dose methotrexate
Annals of Internal Medicine
Lymphadénopathie angio-immunoblastique survenant deux ans après une vascularite d'hypersensibilité
Semaine des Hôpitaux de Paris
Renal manifestations of the Henoch-Schönlein syndrome in adults
American Journal of Medicine
Vasculitis and vitamin abuse
Archives of Pathology and Laboratory Medicine
A case of Henoch-Schönlein purpura syndrome following oral ampicillin
Journal of Antimirobial Chemotherapy
Phenylbutazone liver injury: a clinical pathologic survey of 23 cases and review of the literature
Hepatology
Hydralazine induced cutaneous vasculitis
British Medical Journal
Localized cutaneous leukocytoclastic vasculitis in an intravenous drug abuser
International Journal of Dermatology
Human serum sickness: a prospective analysis of 35 patients treated with equine anti-thymocyte globulin for bone marrow failure
Medicine
Vasculitis with alclofenac therapy
British Medical Journal
The American College of Rheumatology 1990 criteria for the classification of vasculitis: patients and methods
Arthritis and Rheumatology
A possible association between influenza vaccination and small-vessel vasculitis
Archives of Internal Medicine
Trisymptôme de Gougerot induit par les anti-inflammatorires. Rôle du Diclofénac?
Annales de Dermatologie et de Vénéréologie
Allopurinol-hypersensivity vasculitis and liver damage
Western Journal of Medicine
Vasculitis following nifedipine
Harefuah
The American College of Rheumatology 1990 criteria for the classification of hypersensitivity vasculitis
Arthritis and Rheumatology
Cutaneous vasculitis associated with propylthiouracil therapy
Archives of Internal Medicine
Vasculitis, pulmonary cavitation and anemia during antithyroid drug therapy
American Journal of Diseases of Children
Ciprofloxacin induced vasculitis
New England Journal of Medicine
Allergic granulomatosis and angiitis (Churg-Strauss syndrome). Report and analysis of 30 cases
Mayo Clinic Proceedings
Necrotizing angiitis associated with drug abuse
New England Journal of Medicine
Drug induced rheumatic syndromes: diagnosis, clinical features and management
Medical Toxicology and Adverse Drug Experience
Vascularite cutanée bénigne lors d'un traitement par triméthoprime-sulfaméthoxazole
La Nouvelle Presse Médicale
Clinical and immunological aspects of cutaneous vasculitis
Quarterly Journal of Medicine
Potassium iodide sensitivity in four patients with hypocomplementemic vasculitis
Annals of Internal Medicine
An unusual vasculitis due to diphenhydramine
Archives of Dermatology
Immunology of a serum sickness/vasculitis reaction secondary to streptokinase used for acute myocardial infarction
Clinical and Experimental Rheumatology
Three cases resembling polyarteritis nodosa arising during treatment with guanethidine
British Medical Journal
Deposition of immunoglobulin and complement in mucocutaneous lesions related to treatment with d-penicillamine
Journal of Oral Pathology
Hypersensitivity vasculitis induced by terbutaline sulfate
Annals of Allergy
Severe vasculitis during isotretinoin therapy
Archives of Dermatology
Fatal renal vasculitis and minimal change glomerulonephritis complicating treatment with penicillamine. Report on two cases
Acta Medica Scandinavica
The spectrum of vasculitis. Clinical, pathologic, immunologic and therapeutic considerations
Annals of Internal Medicine
Phenytoin induced systemic granulomatous vasculitis
Archives of Pathology and Laboratory Medicine
Propylthiouracil induced cutaneous vasculitis
Acta Dermato-venereologica
Cited by (36)
Hydralazine-induced vasculitis presenting with ocular manifestations
2022, American Journal of Ophthalmology Case ReportsCitation Excerpt :Following discontinuation of hydralazine, both patients experienced a timely recovery with no changes in ocular disease.8 Vasculitic reactions make up 10–20% of drug-induced cutaneous reactions, and among all vasculitides, drug-induced vasculitis is the most common.1,9,10 DIV frequently presents as a cutaneous vasculitis with associated myalgias and arthralgias but may also present with renal and pulmonary manifestations.1
Drug-induced cutaneous vasculitis and anticoagulant-related cutaneous adverse reactions: insights in pathogenesis, clinical presentation, and treatment
2020, Clinics in DermatologyCitation Excerpt :Due to inflammation and necrosis of the small venules with subsequent red blood cell extravasation and inflammatory changes, the hallmark primary cutaneous lesions are tender, palpable nonblanching purpuric papules (Figure 2A, B).29 Given a single trigger, all lesions tend to present in a single crop and are of similar duration27; however, there is a spectrum of manifestations ranging from punctate small petechiae to large confluent purpuric patches, papules, nodules, and plaques (Figure 2B). With exuberant inflammatory changes and superficial infarction from focal ischemia, vesicular (Figure 3), bullous (Figure 4), pustular (Figure 5), or ulcerated papules and plaques may occur (Figure 6).10,12,16,29–32
Letrozole-induced necrotising leukocytoclastic small vessel vasculitis: First report of a case in the UK
2015, International Journal of Surgery Case ReportsCitation Excerpt :Leukocytoclastic vasculitis is an immune complex-mediated reactive transient small-vessel vasculitis. It causes 10–20% of all small-vessel vasculitides [9]. Cutaneous leukocytoclastic small vessel vasculitis (CLSVV) is a diagnosis of exclusion, and infection and connective tissue disease need to be ruled out by negative ANCA levels and through biopsy.
Drug eruptions and other adverse drug effects in aged skin
2002, Clinics in Geriatric MedicineDrug-induced vasculitis
2001, Rheumatic Disease Clinics of North AmericaCitation Excerpt :At a minimum, case reports of DIV should include proper documentation of the timing of drug administration; the exclusion of other agents and other types of vasculitis; and detailed clinical data, including pathologic descriptions if applicable.46,68,89,97 Table 1 lists many of the agents reported in the English language literature to cause vasculitis.1,5,6,16,18,22,25,32,40,43,48,51,57,67,80,82,87,92,93,102,105,106 Although not complete, this list demonstrates the wide variety of drug classes implicated in DIV.
Autoimmune diseases associated with drugs, chemicals and environmental factors
2000, Toxicology Letters